Severity of Hypertension Mediates the Association of Hyperuricemia With Stroke in the REGARDS Case Cohort Study
- PMID: 31786980
- PMCID: PMC7122733
- DOI: 10.1161/HYPERTENSIONAHA.119.13580
Severity of Hypertension Mediates the Association of Hyperuricemia With Stroke in the REGARDS Case Cohort Study
Abstract
Previous studies do not widely support hyperuricemia as a risk factor for stroke and other cardiovascular diseases. We assessed the relationship between hyperuricemia and ischemic stroke (≈900 cases) using a large data set from the REGARDS study (Reasons for Geographic and Racial Differences in Stroke). We employed a case-cohort design (incident stroke cases and randomly selected cohort participants) and weighted Cox-proportional hazard models to estimate the association of serum urate level ≥6.8 mg/dL (ie, hyperuricemia) and 6.0 to <6.8 mg/dL versus <6.0 mg/dL (reference) with incident stroke. Analyses were stratified by race, gender, and age. Mediation of cardiovascular disease comorbidities on the serum urate-stroke association was tested. Hyperuricemia was associated with stroke (hazard ratio, 1.40 [95% CI, 1.10-1.78]) after adjustment for demographic variables and systolic and diastolic blood pressure. This association was substantially attenuated (hazard ratio, 1.17 [95% CI, 0.90-1.51]) by additional covariate adjustment. In particular, apparent treatment-resistant hypertension (systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg on 3 antihypertensive medications or use of ≥4 antihypertensive medications) and the count of antihypertensive medication classes significantly reduced the effect of hyperuricemia on ischemic stroke. Specifically, apparent treatment-resistant hypertension and number of antihypertensive, respectively, mediate 45% and 43% of the association. There was no effect modification in the association between hyperuricemia and stroke by age, race, or gender. We conclude that hyperuricemia may be a risk factor for stroke. The substantial attenuation of this association by apparent treatment-resistant hypertension and number of antihypertensive suggests that severe hypertension may be a mediator.
Keywords: blood pressure; comorbidity; hypertension; hyperuricemia; uric acid.
Similar articles
-
Hypertension severity, apparent treatment resistant hypertension and hyperuricemia in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.J Hypertens. 2023 Jun 1;41(6):1033-1039. doi: 10.1097/HJH.0000000000003425. Epub 2023 Apr 4. J Hypertens. 2023. PMID: 37016935
-
Microalbuminuria mediates the association between serum uric acid and elevation of blood pressure: a longitudinal analysis in the Gusu cohort.J Hypertens. 2020 Apr;38(4):625-632. doi: 10.1097/HJH.0000000000002316. J Hypertens. 2020. PMID: 31834126
-
Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study.J Am Heart Assoc. 2017 Nov 4;6(11):e006683. doi: 10.1161/JAHA.117.006683. J Am Heart Assoc. 2017. PMID: 29102979 Free PMC article. Clinical Trial.
-
The Association of Febuxostat Compared With Allopurinol on Blood Pressure and Major Adverse Cardiac Events Among Adult Patients With Hyperuricemia: A Meta-analysis.J Cardiovasc Pharmacol. 2020 Oct;76(4):461-471. doi: 10.1097/FJC.0000000000000871. J Cardiovasc Pharmacol. 2020. PMID: 32675751
-
Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study.Am J Kidney Dis. 2014 May;63(5):781-8. doi: 10.1053/j.ajkd.2013.11.016. Epub 2014 Jan 1. Am J Kidney Dis. 2014. PMID: 24388119 Free PMC article. Review.
Cited by
-
Update on the epidemiology, genetics, and therapeutic options of hyperuricemia.Am J Transl Res. 2020 Jul 15;12(7):3167-3181. eCollection 2020. Am J Transl Res. 2020. PMID: 32774692 Free PMC article. Review.
-
Dysuricemia-A New Concept Encompassing Hyperuricemia and Hypouricemia.Biomedicines. 2023 Apr 23;11(5):1255. doi: 10.3390/biomedicines11051255. Biomedicines. 2023. PMID: 37238926 Free PMC article. Review.
-
Serum uric acid as a predictor of mortality in patients with stroke: results from National Health and Nutrition Examination Survey 2007-2016.Front Neurol. 2024 Jun 26;15:1383300. doi: 10.3389/fneur.2024.1383300. eCollection 2024. Front Neurol. 2024. PMID: 38988602 Free PMC article.
-
Hyperuricemia is Related to the Risk of Cardiovascular Diseases in Ethnic Chinese Elderly Women.Glob Heart. 2022 Feb 22;17(1):12. doi: 10.5334/gh.1102. eCollection 2022. Glob Heart. 2022. PMID: 35342699 Free PMC article.
-
Nucleosides Associated With Incident Ischemic Stroke in the REGARDS and JHS Cohorts.Neurology. 2022 May 24;98(21):e2097-e2107. doi: 10.1212/WNL.0000000000200262. Epub 2022 Mar 9. Neurology. 2022. PMID: 35264422 Free PMC article.
References
-
- Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the us general population: The national health and nutrition examination survey 2007–2008. Arthritis Rheum. 2011;63:3136–3141 - PubMed
-
- Borghi C, Rosei EA, Bardin T, Dawson J, Dominiczak A, Kielstein JT, Manolis AJ, Perez-Ruiz F, Mancia G. Serum uric acid and the risk of cardiovascular and renal disease. J Hypertens. 2015;33:1729–1741; discussion 1741 - PubMed
-
- Abeles AM. Hyperuricemia, gout, and cardiovascular disease: An update. Curr Rheumatol Rep. 2015;17:13. - PubMed
-
- Culleton BF, Larson MG, Kannel WB, Levy DJAoim. Serum uric acid and risk for cardiovascular disease and death: The framingham heart study. 1999;131:7–13 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical